Holen Sie sich die Stockscreener-App
0.1754
3.73%
0.0063
VolitionRX Ltd Aktie (VNRX) Neueste Nachrichten
Nasdaq cuts target for VolitionRx stock to USD 13.89 from USD 16.83 - AD HOC NEWS
Neither party sold shares as VolitionRx (VNRX) retained 284 shares for its commercial chief’s taxes. - Stock Titan
No shares were sold as VolitionRx (VNRX) retained 608 COO shares for cancellation to cover taxes. - Stock Titan
VolitionRx stock faces a data driven trading reset - AD HOC NEWS
Lagoda Investment Management, L.P. Trims VolitionRX Ltd (VNRX) S - GuruFocus
VolitionRx Limited stock edges higher as investors weigh recent results - AD HOC NEWS
VolitionRx Limited Shares Further Details On The Official Launch Of The DETECSEPS Project On The Early Detection Of Sepsis - marketscreener.com
VolitionRx joins France sepsis detection consortium By Investing.com - Investing.com Nigeria
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - PR Newswire
VolitionRx Participates in Launch of DETECSEPS Program in France - PR Newswire
A €6.3 million French program will test one blood marker to spot sepsis early - Stock Titan
VolitionRx Shares Further Details and Video of the DETECSEPS Program Launch in France - Nasdaq
One manager now reports nearly 6% of VolitionRx (NYSE: VNRX) - Stock Titan
VolitionRx Limited (AMEX:VNRX) Prepays $7.5M Convertible Note, Cuts Dilution Risk - TradingView
VolitionRx Limited Announces Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note Due May 20, 2027 - Yahoo Finance
VNRX: VolitionRx Prepays Outstanding Balance on the $7,500,000 Lind Senior Secured Convertible Promissory Note Dated May 20, 2025. Review of Papers, Posters, and Videos Released in Mid-2026. Sysmex Collaboration is the 3rd Recent Agreement in t - Yahoo Finance
VolitionRX Limited Announces Pre-Payment in F - Moomoo
VOLITIONRX LTD SEC Filing (Sep 11, 2026) - Stock Titan
Lagoda Investment Management, L.P. Adds VolitionRX Ltd (VNRX) -- Shares Look 98% Undervalued on GF Value - GuruFocus
VNRX Looks 98.1% Undervalued on GF Value™ Despite Financial Dist - GuruFocus
A blood-based method detected 95% of stage I and II cancers. - Stock Titan
Dilution risk flagged as VolitionRx (NYSE: VNRX) registers more Lind shares for resale - Stock Titan
VolitionRx (NYSE: VNRX) details Lind note and warrant stake under 4.99% cap - Stock Titan
Lagoda Investment Management Elevates VOLITIONRX LTD (AMEX: VNRX) Stake to Activist 13D Filing at 7.4% - kalkinemedia.com
VNRX - Finviz
Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake - tradingview.com
$11M VolitionRx (VNRX) stake comes with call to cut executive pay - Stock Titan
VolitionRx Removes $10M Annual Cap on ATM Sales Via Lind Waiver - Minichart
$VolitionRX (VNRX.US)$ it be like that. not even tripping cuz! - Moomoo
VolitionRx Files for Secondary Offering of Common Shares - Moomoo
This $21 Stock Has CRAZY Potential Baby Sleep (NynJ4YJi1C) - mshale.com
Nasdaq Surges 200 Points; Nvidia Posts Upbeat Q2 Results - Sahm
VolitionRx Files for Secondary Offering of Common Shares - Yahoo Finance
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Benzinga
$VolitionRX (VNRX.US)$ - Moomoo
Penny Stock VolitionRx Expands Addressable Markets With Key Diagnostic Validations - Yahoo Finance
VolitionRx revenue rises 112% in H1FY26; shares surge 100% - scanx.trade
VolitionRx Highlights Commercial Momentum and Multi-Pillar Execution Across $27+ Billion Total Addressable Markets - Yahoo Finance
Volition's sepsis biomarker predicts 28-day death and kidney treatment needs - Stock Titan
VNRX Looks 97.8% Undervalued on GF Value™ - GuruFocus
VolitionRX Ltd (VNRX) (Q2 2026) Earnings Call Highlights: Strate - GuruFocus
Benchmark reiterates Hold on VolitionRX stock amid cost cuts - Investing.com
Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com Canada
Benchmark reiterates Hold on VolitionRX stock amid cost cuts By Investing.com - Investing.com India
VNRX Looks 97.6% Undervalued on GF Value™ - GuruFocus
Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G - Stock Titan
Teleconferência de Resultados do 2º Trimestre de 2026 da VolitionRx (VNRX): Custos Caem à Medida que o Pipeline Nu.Q Avança - TradingKey
Conferencia de resultados del Q2 de 2026 de VolitionRx (VNRX): los costos caen a medida que avanza la cartera de desarrollo de Nu.Q - TradingKey
VolitionRx (VNRX) Q2 2026 Ergebniskonferenz: Kosten sinken bei Fortschritten der Nu.Q-Pipeline - TradingKey
Volitionrx Ltd earnings beat by $0.06, revenue fell short of estimates - Investing.com Canada
4.45%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):